Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes

Malignant pleural mesothelioma is a rare, aggressive, and incurable cancer with a poor prognosis and high symptom burden. For these patients, little is known about the impact of palliative care consultation on outcomes such as mortality, hospital admissions, or emergency department visits. The aim o...

Full description

Bibliographic Details
Main Authors: Andrew Baird, Abdullah Nasser, Peter Tanuseputro, Colleen Webber, Paul Wheatley-Price, Camille Munro
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/31/2/76
_version_ 1827343828096385024
author Andrew Baird
Abdullah Nasser
Peter Tanuseputro
Colleen Webber
Paul Wheatley-Price
Camille Munro
author_facet Andrew Baird
Abdullah Nasser
Peter Tanuseputro
Colleen Webber
Paul Wheatley-Price
Camille Munro
author_sort Andrew Baird
collection DOAJ
description Malignant pleural mesothelioma is a rare, aggressive, and incurable cancer with a poor prognosis and high symptom burden. For these patients, little is known about the impact of palliative care consultation on outcomes such as mortality, hospital admissions, or emergency department visits. The aim of this study is to determine if referral to supportive and palliative care in patients with malignant pleural mesothelioma is associated with survival and decreased hospital admissions and emergency department visits. This is a retrospective chart review. Study participants include all malignant pleural mesothelioma patients seen at The Ottawa Hospital—an acute care tertiary center—between January 2002 and March 2019. In total, 223 patients were included in the study. The mean age at diagnosis was 72.4 years and 82.5% were male. Of the patients diagnosed between 2002 and 2010, only 11 (9.6%) were referred to palliative care. By comparison, of those diagnosed between 2011 and 2019, 49 (45.4%) were referred to palliative care. Median time from diagnosis to referral was 4.1 months. There was no significant difference in the median survival of patients referred for palliative care compared to those who did not receive palliative care (<i>p</i> = 0.46). We found no association between receiving palliative care and the mean number of hospital admissions (1.04 vs. 0.91) from diagnosis to death, and an increase in mean number of emergency department visits in the palliative care group (2.30 vs. 1.18). Although there was increased utilization of palliative care services, more than half of the MPM patients did not receive palliative care despite their limited survival. There was an increase in emergency department visits in the palliative care group; this may represent an increase in the symptom burden (i.e., indication bias) in those referred to palliative care.
first_indexed 2024-03-07T22:36:57Z
format Article
id doaj.art-d3a08fb0ebe94afc82ab281437b5c61e
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-07T22:36:57Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-d3a08fb0ebe94afc82ab281437b5c61e2024-02-23T15:13:27ZengMDPI AGCurrent Oncology1198-00521718-77292024-02-013121028103410.3390/curroncol31020076Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life OutcomesAndrew Baird0Abdullah Nasser1Peter Tanuseputro2Colleen Webber3Paul Wheatley-Price4Camille Munro5Department of Medicine, University of Ottawa, Ottawa, ON K1H 8L6, CanadaDepartment of Oncology, Western University, London, ON N8W 2X3, CanadaDepartment of Medicine, University of Ottawa, Ottawa, ON K1H 8L6, CanadaBruyère Research Institute, Ottawa, ON K1R 6M1, CanadaDepartment of Medicine, University of Ottawa, Ottawa, ON K1H 8L6, CanadaDepartment of Medicine, University of Ottawa, Ottawa, ON K1H 8L6, CanadaMalignant pleural mesothelioma is a rare, aggressive, and incurable cancer with a poor prognosis and high symptom burden. For these patients, little is known about the impact of palliative care consultation on outcomes such as mortality, hospital admissions, or emergency department visits. The aim of this study is to determine if referral to supportive and palliative care in patients with malignant pleural mesothelioma is associated with survival and decreased hospital admissions and emergency department visits. This is a retrospective chart review. Study participants include all malignant pleural mesothelioma patients seen at The Ottawa Hospital—an acute care tertiary center—between January 2002 and March 2019. In total, 223 patients were included in the study. The mean age at diagnosis was 72.4 years and 82.5% were male. Of the patients diagnosed between 2002 and 2010, only 11 (9.6%) were referred to palliative care. By comparison, of those diagnosed between 2011 and 2019, 49 (45.4%) were referred to palliative care. Median time from diagnosis to referral was 4.1 months. There was no significant difference in the median survival of patients referred for palliative care compared to those who did not receive palliative care (<i>p</i> = 0.46). We found no association between receiving palliative care and the mean number of hospital admissions (1.04 vs. 0.91) from diagnosis to death, and an increase in mean number of emergency department visits in the palliative care group (2.30 vs. 1.18). Although there was increased utilization of palliative care services, more than half of the MPM patients did not receive palliative care despite their limited survival. There was an increase in emergency department visits in the palliative care group; this may represent an increase in the symptom burden (i.e., indication bias) in those referred to palliative care.https://www.mdpi.com/1718-7729/31/2/76palliative caremesotheliomasurvivalemergency departmentspatient admission
spellingShingle Andrew Baird
Abdullah Nasser
Peter Tanuseputro
Colleen Webber
Paul Wheatley-Price
Camille Munro
Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes
Current Oncology
palliative care
mesothelioma
survival
emergency departments
patient admission
title Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes
title_full Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes
title_fullStr Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes
title_full_unstemmed Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes
title_short Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes
title_sort involvement of palliative care in malignant pleural mesothelioma patients and associations with survival and end of life outcomes
topic palliative care
mesothelioma
survival
emergency departments
patient admission
url https://www.mdpi.com/1718-7729/31/2/76
work_keys_str_mv AT andrewbaird involvementofpalliativecareinmalignantpleuralmesotheliomapatientsandassociationswithsurvivalandendoflifeoutcomes
AT abdullahnasser involvementofpalliativecareinmalignantpleuralmesotheliomapatientsandassociationswithsurvivalandendoflifeoutcomes
AT petertanuseputro involvementofpalliativecareinmalignantpleuralmesotheliomapatientsandassociationswithsurvivalandendoflifeoutcomes
AT colleenwebber involvementofpalliativecareinmalignantpleuralmesotheliomapatientsandassociationswithsurvivalandendoflifeoutcomes
AT paulwheatleyprice involvementofpalliativecareinmalignantpleuralmesotheliomapatientsandassociationswithsurvivalandendoflifeoutcomes
AT camillemunro involvementofpalliativecareinmalignantpleuralmesotheliomapatientsandassociationswithsurvivalandendoflifeoutcomes